These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2872679)

  • 21. The role of functional cell surface antigens in T cell activation.
    Bierer BE; Mentzer SJ; Greenstein JL; Burakoff SJ
    Year Immunol; 1986; 2():39-59. PubMed ID: 2953146
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [T cells and cellular immunity; T receptors (structure, diversity, repertory); differentiation antigens (CD4, CD8); activation; auxillary T cells and immunoregulation; lymphokines (interferons, TNF, IL-1, IL-2, IL-4) and cytotoxicity; concept of cellular immunity deficit].
    Moreau JF; Dechanet-Merville J; Taupin JL
    Rev Prat; 2000 Dec; 50(19):2183-93. PubMed ID: 11213465
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immunity in nutritional deficiency.
    McMurray DN
    Prog Food Nutr Sci; 1984; 8(3-4):193-228. PubMed ID: 6396715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cell-mediated immunity. The cellular network in its induction and manifestation].
    Saito K
    Nihon Saikingaku Zasshi; 1980 Nov; 35(6):721-37. PubMed ID: 6972459
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation among T lymphocytes. The cloning approach.
    Miller JF
    Oncodev Biol Med; 1982; 4(1-2):31-51. PubMed ID: 6217451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and function of MHC: molecular mechanisms for antigen processing and antigen presentation to T cells].
    Nishimura Y
    Tanpakushitsu Kakusan Koso; 2000 May; 45(7):1205-18. PubMed ID: 10806862
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hypersensitivity and cell-mediated immunity. A survey of current insights into these responses of the body to antigens.
    Maddison SE
    Clin Pediatr (Phila); 1973 Sep; 12(9):529-37. PubMed ID: 4579892
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell-mediated immune reactions.
    Guin JD
    J Indiana State Med Assoc; 1981 Aug; 74(8):512. PubMed ID: 6973597
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The major histocompatibility complex-restricted antigen receptor on T cells. IX. Role of accessory molecules in recognition of antigen plus isolated IA.
    Gay D; Coeshott C; Golde W; Kappler J; Marrack P
    J Immunol; 1986 Mar; 136(6):2026-32. PubMed ID: 3512708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Discovery of MHC restriction in antigen recognition of T cells].
    Lan GT; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):539-41. PubMed ID: 12905783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell differentiation.
    Miller RG
    Int J Cell Cloning; 1986; 4 Suppl 1():26-38. PubMed ID: 2943826
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
    Rinaldo CR; Torpey DJ
    Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.